Clinical Trial Update: Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating steady-state pharmacokinetics, efficacy, and safety of nevirapine in antiretroviral-naïve pediatric HIV patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 2 | Status: COMPLETED